KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Healthcare

KAERI Successfully Produces Isotope for Cancer Treatment

James Jung by James Jung
PUBLISHED: March 4, 2020 UPDATED: March 6, 2020
in Healthcare, Korea Atomic Energy Research Institute, Medical industry, South Korea
0
kaeri-produces-cu-67-for-cancer-treatment
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI

KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI

The Korea Atomic Energy Research Institute (KAERI) reported on Wednesday that it succeeded in producing a medical isotope that can be simultaneously used for cancer diagnosis and treatment. The government-owned atomic research agency’s Advanced Radiation Technology Institute succeeded in creating isotope copper-67 (Cu-67), by utilizing its RFT-30 cyclotron particle accelerator.

Next-Generation Cancer Treatment

The Cu-67, widely considered as a next-generation radioisotope for cancer treatment, emits both cancer therapeutic beta rays and cancer diagnostic gamma rays. The isotope possesses excellent therapeutic effects with a relatively short “half-life,” meaning its radioactivity dissipates faster than that of other isotopes.

The radioisotope helps antibodies in destroying cancerous tumors when injected with monoclonal antibodies into a patient. KAERI proudly stated that Cu-67 successfully destroyed 80 percent of lung cancer cells during cellular experiments.

A KAERI official said that peptides o antibodies that contain the Cu-67 could carry out both therapy and scanning, unlike PET scans, which are used only for diagnosing cancer. The official added that Cu-67 short half-life of 2.6 days means it is less dangerous than previous diagnostic and treatment measures.

Cu-67 Production

KAERI said that at present, around ten organizations are hoping to acquire the isotope. The institute’s technique can produce a dozen of mCi of Cu-67 enough to supply three institutions at a time. The Chonnam National University Hospital and the Seoul National University Hospital already expressed their interest in the medical radioisotope.

The atomic research institute utilized its RFT-30 cyclotron particle accelerator to develop the medical radioisotope using proton beams. Starting in the second half of 2020, KAERI will supply the Cu-67 to local medical institutions.

However, Cu-67 takes a lot of time to produce because of the complexity of the procedure and the high costs it requires. Lee Kyung-han, president of the Korean Society of Nuclear Medicine, said that the advancement of Cu-67 would contribute to the development of South Korea’s nuclear medicine technology.

Lee also said that the successful production and supply of Cu-67 would launch the country to a new chapter in therapeutics and simultaneous diagnosis.

Wi Myung-hwan said that the establishment of a Cu-67 production system would aid the nation in becoming the leader in next-generation cancer treatments. Wi is the senior vice president of the KAERI’s Advanced Radiation Technology Institute.

KAERI plans to increase the production capacity to hundreds of mCi for export to Asian countries.

Tags: cancer treatmentCu-67diagnosisKAERIparticle acceleratorradioisotope

Related Posts

Chazm Operator Wins Scale-up TIPS Selection to Expand Automotive Finance AI
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
AI

Chazm Operator Wins Scale-up TIPS Selection to Expand Automotive Finance AI

November 4, 2026
Why the Future of Digital Healthcare May Be Built Around Families, Not Just Patients
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
Healthcare

Why the Future of Digital Healthcare May Be Built Around Families, Not Just Patients

November 1, 2026
Why Healthcare Technology Must Adapt to How People Actually Live
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
Healthcare

Why Healthcare Technology Must Adapt to How People Actually Live

November 1, 2026
The Strategic Investment Trap: What Korean Startup Founders Should Consider Before Taking Corporate VC
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
AI

The Strategic Investment Trap: What Korean Startup Founders Should Consider Before Taking Corporate VC

November 1, 2026
India and South Korea Could Build a New Startup Corridor Around Manufacturing and Technology
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
South Korea

India and South Korea Could Build a New Startup Corridor Around Manufacturing and Technology

November 1, 2026
Why South Korea Could Become a Strategic Growth Partner for Southeast Asian Startups
KAERI’s RFT-30 cyclotron particle accelerator used for Cu-67 radioisotope production. / photo courtesy of KAERI
South Korea

Why South Korea Could Become a Strategic Growth Partner for Southeast Asian Startups

November 1, 2026
No Result
View All Result

Most Popular

  • Naver Pay Reaches 30.68 Million Users, Expands Global and Local Payment Services

    0 shares
    Share 0 Tweet 0
  • Why South Korea’s Hyperconnected Economy Needs a More Integrated Cybersecurity Strategy

    0 shares
    Share 0 Tweet 0
  • Kakao in Talks to Sell Daum, With AI Startup Upstage as Top Contender

    0 shares
    Share 0 Tweet 0
  • LG Uplus Introduces OpenAI-Powered Agentic Callbot for Customer Phone Support

    0 shares
    Share 0 Tweet 0
  • Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

[mc4wp_form id="4726"]

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |